Nondemented older subjects with cognitive impairment are at higher risk of death than are mentally intact persons. It is unknown whether the effect of cognitive impairment on mortality is independent or mediated by poorer health or other factors. To address this issue, the authors used a prospective population-based cohort study with 8 years of follow-up started in 1987 in the urban district of Kungsholmen, Stockholm, Sweden. Subjects were all 75-to 95-year-old subjects nondemented at baseline (n = 1,435). Data on cognition, health (mental and subjective health, physical diseases and comorbidity, nutritional status, and disability), and apotipoprotein E genotype were collected at baseline as was time of death at follow-up. Cognitive impairment was defined on the basis of age-and education-specific cutoffs on the Mini-Mental State Examination. When compared with cognitively unimpaired subjects (n = 1,210), those cognitively impaired (n = 225) had poorer health conditions, were more frequently apolipoprotein E e4 carriers, and had greater mortality risk (hazard ratio = 1.7; 95% confidence interval: 1.5, 2.1). Neither health nor apolipoprotein E genotype accounted for the association of cognitive impairment with mortality (adjusted hazard ratio = 1.6; 95% confidence interval: 1.3, 1.9). The functional and behavioral consequences associated with the progression of cognitive impairment may mediate the increased mortality risk. Am J Epidemiol 1999;150:1031-44. aged; apolipoproteins E; chronic disease; cognition; comorbidity; dementia; frail elderly; health Cognitive impairment in elderly populations is a major health issue as it is frequently associated with dementia and disability in daily activities. It has been suggested that the largest proportion of disability in daily activities affecting the elderly can be attributed to the cognitive impairment of dementia (1-3). However, while prevalence and correlates of dementing cognitive impairment are well defined (4, 5), little is still known about the clinical correlates and prognosis of those milder cognitive disturbances that are not severe enough to be diagnosed as dementia.
tional) sample of more than 10,000 elders aged 65 years and over, Graham et al. (6) from the Canadian Study of Health and Aging found that the prevalence of cognitive impairment with no dementia was 16.8 percent, while all dementias together amounted to 8 percent. Other authors (7) (8) (9) have indicated that the condition is associated with poorer survival when compared with normal cognition. However, subjects with cognitive impairment are usually older, and their health is poorer than that of their cognitively unimpaired peers (6) (7) (8) (9) (10) , leading to the hypothesis that age and diseases (such as depression, vascular diseases, diabetes, or physical comorbidity in general) (11) (12) (13) rather than cognitive impairment per se might be responsible for the differential mortality.
The aim of this study is to test whether the excess mortality associated with cognitive impairment is due to poorer health or is independent from health factors. The clarification of this issue is relevant in that different scenarios may lead to radically different health policies focusing on prevention and treatment of diseases rather than on cognitive impairment. The recently available antidementia drugs (14) further enhance the relevance of this topic. Different aspects of health will be considered, such as mental, subjective, and physical health (individual diseases, comorbidity, and nutritional status), and disability. Genetic factors that are known to be associated with physical and mental health (apolipoprotein E genotype) will also be addressed.
MATERIALS AND METHODS

Study population and design
These data come from a study initiated in 1987 (the Kungsholmen Project) and aimed at assessing the occurrence and natural history of dementia in the general population (15) . Briefly, the baseline data collection of the project consisted of a two-phase door-todoor survey to detect the prevalence of dementia cases in all those 2,368 subjects born in 1912 or earlier who were residing in the Kungsholmen district, Stockholm, on October 1, 1987 . The Kungsholmen is a residential district located in the central urban area of Stockholm with a remarkably stable population. The demographic data of residents as well as on migration were obtained from the administrative office of the district. The screening phase was carried out from October 1987 to September 1989; 87 percent of the subjects were screened within 12 months. Potentially demented subjects were identified with a cognitive test (Swedish version of the Mini-Mental State Examination (MMSE)) (16, 17) and underwent clinical examination and detailed neuropsychologic testing to confirm dementia on the basis of Diagnostic and Statistical Manual of Mental Disorders: DSM IHR (DSM-HIR) criteria (15, 18) . Dementia was defined as meeting at least four of the five DSM-DIR criteria (18, 19) : evidence of impairment of short-and long-term memory, change in at least one other neuropsychologic or personality domain, interference with usual daily activities, absence of delirium, and either evidence of a responsible organic factor or absence of any potentially responsible mental factor (such as depression).
Of the 2,368 subjects, 267 had died or changed address before the screening examination. Of the 2,101 eligible subjects, 291 (14 percent) refused the interview. Of the 1,810 screened subjects, 385 scored under the cutoff for dementia screening (23/24) on the MMSE. These and a stratified (by age and sex) random sample of 354 subjects taken from all those scoring above the cutoff underwent clinical examination (19) . A total of 110 subjects could not (dead or moved) or would not (refusal) undergo the clinical examination. At the end of the clinical examination phase, 225 subjects were identified as having definite or questionable dementia, and 1,475 were considered to be not demented (19) .
In this study, a few of the 1,475 nondemented subjects were excluded because of a score lower than 20 on the MMSE (n = 31), unknown educational background (n = 6), and age over 95 years (n = 3). Therefore, the study population consisted of 1,435 nondemented subjects aged 75-95 years.
Informed consent was requested from subjects on screening evaluation. The aim of the project was explained, and confidentiality of the information provided by the subjects was stressed. All phases of the project have received approval from the ethics committee of the Karolinska Institute (20) .
Definition of cognitive Impairment
Two definitions of cognitive impairment were tested, both based on the MMSE and taking into account the effect of age and education. A detailed description and the administration and scoring method of the MMSE have been previously reported (17) . It should be noted that the MMSE items that could not be carried out because of visual, hearing, or other impairments were scored as zero.
Cognitive impairment was defined as achieving an MMSE score 1 standard deviation below the age-and education-specific means. These were computed on the basis of a statistical model and of simple stratification.
Statistical model. Exploratory analyses with generalized additive models (locally weighted regression) (21) suggested that the MMSE score had a mild decline with older age until approximately age 90, when the slope of the decline became steeper. This pattern held for both high and low levels of education. The relation was modeled with a B-spline with one knot at age 88 (figure 1) (22) . B-splines are piecewise cubic polynomials that constitute a good compromise between the explicitly local fit of locally weighted regression and the global fit of polynomial regression, in that the fit is less constrained than that of polynomials, but it is smoother than that of locally weighted regression. The B-spline that was fitted to our data had a better fit than a linear model and than other B-splines with a larger number or different position of knots. Its fitted values (see figure 1 ) and residuals were computed. Since the variability of the residuals increased linearly with increasing age (see also the work by Crum et al. (23) ), and this tendency was significantly more pronounced for the more highly educated subjects, cutoffs for cognitive impairment were computed by modeling the standard deviation of the residuals with a linear model that allowed for different slopes in each educational stratum. The resulting cutoffs ranged from 27/28 for those aged 75 years with a high education to 21/22 for those aged 95 years with a low education (figure 1).
It should be emphasized that this approach assumes a gaussian distribution of MMSE score by levels of strata. Subjects below 1 standard deviation from the mean for each stratum were defined as cognitively impaired. Cutoffs separating cognitively impaired from cognitively unimpaired subjects were very similar to those identified wim the first definition. Cutoffs ranged from 26/27 for those aged 75-78 years with a high education to 23/24 for those aged 87-95 years with a low education. A total of 214 subjects (14.9 percent) were identified as having cognitive impairment. Of the subjects identified as cognitively impaired by the first and second, 98 and 99 percent were identified as cognitively impaired also by the other method, respectively.
The working hypothesis of the study was tested with both definitions of cognitive impairment. Since results were very similar, the results reported in the tables and following figures refer to computations made on the basis of the first definition.
Study variables
All variables except apolipoprotein E genotype were collected during the screening evaluation. Apolipoprotein E genotype was ascertained partly at screening and partly on a follow-up examination carried out from 1991 to 1993.
Sociodemographic variables.
Education was assessed as the maximum educational level achieved. As in previous studies (19) , the two categories of low education (primary school level or less than 8 years of education) and high education (high school to university degree, or 8 or more years of education) were used in the analysis. Living place (nursing home, long-term ward, or in the community) was also recorded.
Mental health. Symptomatic depression was defined as the subjective report of often feeling lonely or often being in a low mood. The use of psychotropic drugs (neuroleptics, benzodiazepines, antidepressants, and other sedatives) was ascertained through interviews and asking to see medicine bottles, prescriptions, and medicine lists (24) . Medications were coded according to the Swedish version of the international World Health Organization classification (25) .
Subjective health. Self-rated health was assessed as a subjective judgment on a 6-point Likert scale and defined as good (very satisfied with health, i.e., the maximum score on the scale) and poorer health (all lower levels). Somatic symptoms were chosen to be representative of the organ systems more frequently affected by disease in the elderly: chest and heart discomfort (cardiovascular system), shortness of breath (respiratory system), digestion troubles (gastroenteric system), joint pain (musculoskeletal system), and poor appetite (general state of health). Subjects were asked concerning the presence or absence of each symptom.
Physical health.
Individual diseases, summary measures of comorbidity, and nutritional status were assessed. Individual diseases were ascertained through the computerized Stockholm Inpatient Registry System by reviewing the hospital discharge diagnoses from 1969 to the date of the screening examination for the entire population (26) . Disease diagnoses were based on the International Classification of Diseases, Eighth Revision (ICD-8) (27) : coronary heart disease (myocardial infarction, angina, and chronic ischemic heart disease, ICD-8 codes 410-414); cerebrovascular disease (stroke and transient ischemic attack, ICD-8 codes 430-438); diabetes mellitus (ICD-8 code 250); malignancy (ICD-8 codes 140-208 and 230-239); and hip fracture (ICD-8 code 820).
Summary measures of comorbidity were the number of diseases, a chronic disease score based on medication data (28) , and the use of health care resources. The number of diseases was the sum of the five individual disease categories affecting a subject. The chronic disease score is computed on the basis of prescribed medications and allows the assignment of a severity-weighted score for 17 diseases or disease groups (heart diseases, respiratory illnesses, asthma, cancer, Parkinson's disease, and so on); the resulting total score is a valid indicator of physical health impairment (28) . Medications were ascertained and coded as described above for psychotropic drugs. The use of health care resources was defined as having been visited at home by a physician or by a registered nurse during the previous 3 months.
Nutritional status was assessed using the body mass index, defined as weight (kg)/height (m) 2 ), height being measured with the subject's standing upright Height was not measured when the patient could not or would not stand. The body mass index is an indicator of conditions of overweight (values of 28 and higher) or underweight (20 and lower), and both high and low values have been shown to be associated with greater mortality (29) . Height and weight data were available for 1,261 subjects (174 cognitively impaired and 1,087 unimpaired). When compared with those with valid data, the 174 subjects for whom data were missing were older (age: 84.1 (standard deviation (SD) = 5.1) years vs. 80.5 (SD = 4.2) years; t = 10.2; df = 1,433; p < 0.0005), more cognitively impaired (MMSE score: 25.7 (SD = 2.1) vs. 27.1 (SD = 1.8); t = 9.2; df=1,433; p < 0.0005), more disabled (one or more basic functions lost: n = 82, 47 percent, vs. n = 258, 21 percent; X 1 = 60.1; df = 1; p < 0.0005), and had greater 8-year mortality (deaths: n = 133, 76 percent, vs. n = 592, 47 percent; yj = 53.8; df = 1; p < 0.0005).
Disability. Basic activities of daily living were assessed as dependency in bathing, dressing, toileting, continence, feeding, and walking (30) .
Information on education, drugs, use of health care resources, and disability was taken from an informant in the case of poor reliability of the subject (in 7.6 percent of the cognitively impaired and 5.3 percent of the unimpaired, p = 0.23). Missing values never exceeded 1.5 percent of the total population for any one variable.
Apolipoprotein E. Genotyping was carried out by DNA microsequencing (AffiGen apolipoprotein E; Sangtec Medical, Bromma, Sweden), as previously described (26) , and was available for 1,067 (149 cognitively impaired and 918 unimpaired) of the 1,435 subjects evaluated at the screening examination. The 368 nongenotyped subjects were older (age: 83.3 (SD = 4.3) years vs. 80.0 (SD = 4.3) years; t = 12.7; df =1,433; p < 0.0005), more cognitively impaired (MMSE score: 26.4 (SD = 2.0) vs. 27.0 (SD = 1.8); t = 5.6; df = 1,433; p < 0.0005), and had greater 8-year mortality (deaths: n = 289/369, 79 percent, vs. n = 436/1,067, 41 percent; £ = 155.3; p < 0.0005). Of those genotyped, 19 subjects (two with and 17 without cognitive impairment) had a 2/4 genotype and were excluded, leaving 1,048 subjects for the analysis of genetic factors. Few of these were homozygous for either the e4 (n = 24) or the e2 (n = 3) allele. Subjects were categorized as e4 or e2 carriers if they carried at least one copy of the e4 or e2 allele.
Mortality data. Information on vital status was obtained every month from official nationwide registers (9) . The first 8 years of follow-up from baseline assessment (the last death occurring on August 22, 1996) were considered. No subject was lost to followup.
The cause of death was ascertained from death certificates and defined as the initial cause of death, that is, the one "preceding or determining the final event." Ascertainment was made on the basis of hospital records. Data about cause of death were available for all those 291 subjects (63 cognitively impaired and 228 noncognitively impaired) who died before 1993, when the first follow-up assessment of the whole population was completed.
Data analysis
Some variables were collapsed into two or three levels on the basis of exploratory analysis of their association with mortality. Age, number of diseases, chronic disease score, body mass index, and apolipoprotein E genotype were categorized into three levels, while two levels were retained for all other variables (see table 1 ).
Survival as related to cognitive impairment and other variables of interest was explored with the Kaplan-Meier method. The risk of death was estimated as a hazard ratio and 95 percent confidence interval in Cox regression models with time of follow-up (in years since baseline evaluation) as a time scale (right censoring). Risk adjustment for sociodemographic variables was made by forcing the latter in the models. The effect modification between cognitive impairment and variables of interest was explored by stratification of Kaplan-Meier curves, and its statistical significance was checked in Cox models in which cognitive impairment, the variable of interest, and their interaction were entered. The independent association of cognitive impairment and variables of interest with mortality was assessed in a single Cox model: sociodemographic variables were first forced in the model, and then cognitive impairment and variables of interest were tested for significance in a stepwise fashion (p < 0.05 to enter and p > 0.10 to remove for the % 2 test of the -2 log likelihood difference). In all instances, variables with more than two levels were always entered as categorical variables.
The effect of age on the relation between cognitive impairment and mortality was also controlled for by estimating the hazard ratio in a Cox model with the subjects' ages as a time scale (left censoring), cognitive impairment and other covariates being the independent variables (31) .
The effect of missing values of apolipoprotein E and body mass index on the association between cognitive impairment and mortality was assessed by sensitivity and multiple imputation analysis, with discriminant and linear regression models, respectively (32) .
The critical level for statistical significance was set at p = 0.05 for all comparisons. Statistical analyses were performed with SPSS and S-plus software (22) . Table 1 shows that cognitively impaired and unimpaired subjects were similar regarding age, sex, and education. A greater proportion of those cognitively impaired were living in an institution. As expected, the large majority of cognitively unimpaired subjects had high MMSE scores (27 or higher), while all cognitively impaired subjects scored lower than 27. The mean age and MMSE score in cognitively impaired and unimpaired subjects were 81.2 (SD = 4.7) years and 80.8 (SD = 4.5) years; t = 1.4; df = l,433;p = 0.13; and 23.8 (SD = 1.5) and 27.5 (SD = 1.3); t = 36.9; df = 1,433; p < 0.0001, respectively. Mental, subjective, and physical health and daily function were generally poorer in the cognitively impaired group. Most of those factors that were not statistically associated with cognitive impairment were nevertheless indicative of poorer or more disadvantageous conditions in this group. Cognitively impaired subjects also had greater frequency of the e4 and lower frequency of the e2 allele.
RESULTS
Am J Epidemiol Vol. 150, No. 10, 1999 (53) 19 (8) 65 (29) 160 (71) 0 (0) 105 (47) 83 (37) 60 (27) 89 (40) 28 (12) 23 (10) 7(3) 32 (14) 19 (8) 59 (26) 24 (11) 74 (33) 16 (7) 33 (15) 27 (16) 23 (13) 76 (34) 59 (40) 12 (8) 152 ( 542 (45) 434 (36) 234 (19) 902 (75) 602 (50) 60 (5) 2(0) 289 (24) 919 (76) 386 (32) 445 (37) 216 (18) 393 (33) 89 (7) 68 (6) 23 (2) 141 (12) 76 (6) 276 (23) 59 (5) 395 (33) 85 (7) 106(9) 149 (14) 108 (10) 264 (22) 230 (26) 131 (15) 573 ( (75) 722 (50) 79 (6) 67 (5) 449(31) 919 (64) 491 (34) 528 (37) 276 (19) 482 (34) 117 (8) 91 (6) 30 (2) 173 (12) 95 (7) 335 (23) 83 (6) 469 (33) 101 (7) 139 (10) 176 (14) 131 (10) 340 (24) 289 (28) 143 (14) 725 ( 
Mortality and Cognitive Impairment 1037
At the end of the 8-year follow-up, about half of the original population had died (table 1) . Eight-year mortality was markedly higher in the cognitively impaired group. Mortality did not show significant variation at different follow-up times: of the 152 cognitively impaired and 570 unimpaired subjects who had died at the end of the 8-year follow-up, 18 (12 percent) and 56 (10 percent) had died within 1 year, and 52 (34 percent) and 187 (33 percent) had died within 3 years, respectively. Figure 2 shows that survival was consistently lower in the cognitively impaired than unimpaired group throughout the follow-up period. The ratios of the hazards for death of the cognitively impaired vs. the unimpaired subjects for each of the 8 years of follow-up were 1.8, 1.4, 1.5, 2.0, 1.7, 1.3, 2.2, and 1.9. This pattern indicates that the cognitively impaired had consistently higher hazards than the cognitively unimpaired group.
Sociodemographic variables were all associated with 8-year mortality (data not shown). As compared with age 75-79, age 80-84 had a 1.7 (95 percent confidence interval (CI): 1.4, 2.0) and age 85 and over had a 3.3 (95 percent CI: 2.8, 4.0) unadjusted greater risk of dying. Female subjects were at lower risk than were males (0.7; 95 percent CI: 0.6, 0.9); the poorly educated were at higher risk than were the highly educated (1.2; 95 percent CI: 1.1, 1.4); and the institutionalized were at higher risk than were community-dwelling subjects (2.4; 95 percent CI: 1.8, 3.1). Table 2 shows that cognitive impairment was associated with a 70 percent greater risk of death (hazard ratio = 1.7) in both unadjusted and sociodemographics-adjusted analyses. The risk of death associated with cognitive impairment was still detectable even if the follow-up was limited to the first year (adjusted hazard ratio = 1.7; 95 percent CI: 1.0, 2.9). Furthermore, the risk of death was not modified by age, hazard ratios being 2.0 (95 percent CI: 1.4, 2.7) in the 75-79 age group, 1.5 (95 percent CI: 1.1, 2.1) in the 80-84 age group, and 1.6 (95 percent CI: 1.2, 2.1) in the 85 years and over age group; the differences of risk across age strata were not significant when tested in a multivariable Cox model in which cognitive impairment, age strata, and their interaction were simultaneously entered. * Estimates are computed In separate Cox regression models on a minimum of 1,414 subjects. The reference group for body mass index Is subjects with values between 20 and 28 and, for the apolipoprotein E genotype, those with the E3/E3 genotype (subjects with the E2/E4 genotype were excluded).
t For each predictor, unadjusted hazard ratios are computed by entering, In as many models, the predictor alone. Hazard ratios adjusted for soclodemographtcs are computed by forcing age (in three levels), sex, education, and living arrangement (all In two levels) In the previous models t Numbers in parentheses, 95% confidence interval. § Data on 1,261 (174 cognltivery Impaired and 1,087 unimpaired) subjects.
H Data on 1,048 (147 cognittvety impaired and 901 unimpaired) subjects.
The exploration of the interaction between cognitive impairment and other selected health variables is shown in figures 3-5. The effect of cognitive impairment on mortality was present independently of all the health factors, including those not shown in the figure.
The statistical significance of the interaction of cognitive impairment with all the predictors was checked in multivariable Cox models in which cognitive impairment, predictor, and their interaction were simultaneously entered. All interactions failed to reach the critical statistical significance level.
Independent associations with mortality were identified by building a Cox model in which sociodemographic variables were first forced into the model and all other predictors (i.e., those reported in table 2 except body mass index and apolipoprotein E genotype) were then selected for inclusion in a stepwise fashion (table 3) . Cognitive impairment was selected in the final model, as were self-rated health, all three measures of comorbidity, one of the five individual indicators of physical health, and disability. Cognitive impairment was still associated with 60 percent greater mortality risk. Controlling for the effect of age in a Cox model with the same covariates but with subjects' age as a time scale resulted in minor changes in risk (hazard ratio = 1.5; 95 percent CI: 1.2, 1.8).
Two separate models were built for those subgroups for whom body mass index and apolipoprotein E genotype were available, by entering the apolipoprotein E genotype or body mass index, sociodemographics, and the predictors shown in table 3. The hazard ratios of cognitive impairment for mortality were 1.5 (95 percent CI: 1.2, 2.0) and 1.6 (95 percent CI: 1.3, 2.0) for each model, respectively. Sensitivity analysis was carried out to overcome the problem of missing values. Discriminant models were used to predict the apolipoprotein E genotype of the missing cases on the basis of age, sex, MMSE score, presence of cognitive impairment, and presence of dementia on follow-up evaluation. The discriminant function was computed on the basis of the valid apolipoprotein E genotypes and applied to the missing cases. Two extreme conditions were tested (i.e., low frequency of the e2 allele and high frequency of the e4 allele, and vice versa), by setting prior probabilities in the discriminant equation according to published frequencies in Caucasian populations with extreme allele frequencies (33) . The Cox model used to produce the data of table 3 was then run again, entering also apolipoprotein E genotype as a covariate whose missing values had been replaced by predicted values. In the two conditions of apolipoprotein E genotype frequency, the point estimates of the hazard ratio of cognitive impairment for mortality were 1.5 and 1.6, very close to those obtained in the original model (1.6; see table 3) . Missing values of the body mass index were predicted by age and sex in a linear regression model; random variance was introduced five times in the predicted residuals; five different sets of predicted body mass index values were obtained; and the original model was run again an equal number of times, each time including one set of the predicted values. The point estimates of the hazard ratio of cognitive impairment for mortality varied at the second decimal figure and were never lower than 1.55. Table 4 shows that the cause of death for those 291 dead subjects who died before the first follow-up examination was not significantly different for cognitively impaired and unimpaired subjects. Heart failure and other vascular heart diseases showed a trend toward greater frequency in the cognitively impaired group when this condition was contrasted with all the others pooled together (% 2 = 3.2, df = 1, p = 0.07). Vascular brain disease was not different between the two groups (x 2 = 0.1, df = \,p-0.78). Separate analyses were carried out also for individual causes of death such as stroke, intracranial hemorrhage, and acute myocardial infarction, but none approached statistical significance.
DISCUSSION
Findings
We have shown that nondemented elderly subjects with cognitive impairment are at a greater risk of death than are their non-cognitively impaired counterparts, independently of other major determinants of mortality in the elderly population, that is, age and health. We used as health indicators those variables that allowed us to encompass both the physical and the subjective/mental component of health, together with genetic factors known to be associated with poorer health, and disability. We devoted special attention to physical t Hazard ratios adjusted for socfodemographics and all independent predictors are computed by forcing into one single Cox regression model age (in three levels), sex, education, and living arrangement (all in two levels) and entering all other predictors in a stepwise fashion.
$ Numbers in parentheses, 95% confidence interval. (16) 18 (29) 8 (13) 7 (11) 1 (2) 1 (2) 1 (2) 3 (5) No (n = 229) 54(24) 39 (17) 54 (24) 26 (11) 24 (11) 9 (4) 67 (23) 49 (17) 72 (25) 34 (12) 31 (11) 10 (3) 11 (4) 5 (2) health by assessing it with a number of indicators such as individual diseases, comorbidity, and nutritional status. None of the variables modified the association of cognitive impairment with mortality. Although a number of studies have reported greater mortality in cognitively impaired subjects (7-9, 34-42), to our knowlAm J Epidemiol Vol. 150, No. 10, 1999 edge no other study has addressed the effect of health in representative population samples of nondemented, cognitively impaired individuals.
The relevance of taking into account a large number of different health factors in studies on predictors of mortality in the population has been recently underscored (43) . In particular, the effect of comorbidity is of great relevance in the elderly. It has been shown that in an older individual the effect on health and mortality of the simultaneous occurrence of a number of conditions confers a risk in excess of the sum of risks of individual conditions alone (44, 45) . Indeed, in our population all three of the indicators of comorbidity, as compared with only one of five individual diseases (diabetes), were independent predictors of mortality.
Methodological Issues
Some limitations of this study should be noted. First, the issue of residual confounding by unmeasured or poorly measured covariates should be considered. Hypertension, smoking, and limited physical activity are known to be associated with greater mortality (46, 47) and were not ascertained in our study. These conditions might affect our results if they were associated with both poorer cognition and greater mortality. This is not the case with smoking and high blood pressure, for both of which an association with better cognition has been shown in a subsample of this population (48, 49) and by others (50, 51) . On the contrary, our results might be affected by physical activity, which is known from clinical studies to be directly related to cognitive performance (52) . However, there still needs to be clarification of whether, in the general population, limited physical activity comes first and poor cognitive performance follows, or vice versa. Other conditions that are believed to be associated with mortality in the elderly, such as extreme values of body mass index (29) and the e4 allele of apolipoprotein E genotype (53), have been assessed in only subgroups of our population and might need more exhaustive study in future research.
The method of disease ascertainment that we used (hospital discharge records) might have led to incomplete ascertainment of the prevalence of some diseases associated with both cognitive impairment and mortality. This might be the case with diabetes, for the prevalence of this disease in our population was only 2 percent. This value is low if compared with previous surveys (54) and consistent with the view that only the most severe cases of diabetes might have been recorded in hospital discharge charts. Since even subclinical diabetes has been shown to be associated with poor cognition (12) , and diabetes is strongly associated with greater mortality, the effect of diabetes on the association between cognitive impairment and mortality needs further investigation.
Second, the issue of how we defined cognitive impairment deserves discussion. Our definition of cognitive impairment explicitly takes into account the effect of age and education on cognitive performance. Moreover, the definition was based on performance on a widely used psychometric instrument (the MMSE). Although this is poorly sensitive to subtle differences of cognitive performance, it is probably closer to the clinician's perception of cognitive change than are more accurate and detailed neuropsychologic tests (55) .
Finally, it should be emphasized that the severity of cognitive impairment of our cognitively impaired subjects was mild when compared with age-specific population normative values. The mean MMSE score of cognitively impaired subjects was around 24, and age was around 81 years. At this age, the normative median MMSE score is 25, and the lower quartile cutoff is 21/22 (23) . This suggests that the majority of our cognitively impaired subjects have a cognitive performance between the 25th and the 50th centile of the normal distribution.
Interpretation
Some explanations of our findings can be proposed. The so-called "terminal decline" has been advocated to explain the greater mortality of cognitively impaired subjects (8, 56) . In this view, cognitive decline might be a consequence of the physiologic changes occurring in people with impending death. We believe that this explanation is unlikely for a number of reasons. First, subjects with impending death represent a minority of all the elderly population and are, by definition, eliminated early. Thus, their number should be relatively small in any cross-sectional population-based analysis. Second, if the greater mortality of cognitively impaired subjects were due to terminal decline, the risk of death soon after baseline evaluation should be higher in the cognitively impaired group and similar to that of the cognitively unimpaired group at later observation times. This does not seem to be the case in our population, in which the risk of death was higher in the cognitively impaired subjects in the first year of follow-up as well as in the following years.
The so-called "psycho-endocrino-immunologic" theory (57) should also be considered. Some authors believe that primarily mental changes such as depression and bereavement can adversely affect some endocrine and immunologic parameters whose alteration might in turn adversely affect survival (58) . In fact, it has been shown that in frail subjects a condition of enhanced alertness, motivation, and high life expecAm J Epidemiol Vol. 150, No. 10, 1999 Mortality and Cognitive Impairment 1043 tations is able to postpone death (59) , while one of depression and hopelessness is believed to increase the susceptibility to fatal events (60) . Greater frequency of depression (61, 62) , decreased curiosity and motivation to explore the surrounding environment (63) , and diminished alertness (64) have been shown in cognitively impaired patients. Although the effect of mild cognitive impairment on physiologic parameters is not known, this explanation might be consistent with the lack of association of cognitive impairment with cause of death and might deserve further investigation.
A third hypothesis is that the association of cognitive impairment with mortality might be mediated by dementia. In fact, it is true that: 1) in our population, incident dementia after about 3 years from baseline was more frequent in the cognitively impaired than unimpaired subjects (28 vs. 10 percent), and 2) in our own and other populations, survival is poorer in the demented as compared with the nondemented subjects (3, 65, 66) . The plausibility of this hypothesis is supported by the observation that the change of cognitive function over time is a stronger predictor of mortality than is the absolute level of cognitive function (67) .
In conclusion, cognitive impairment is a major prognostic factor of decreased survival in the nondemented elderly, and its effect does not seem to be mediated by age, health, disability, and apolipoprotein E genotype. We believe that the reciprocal links between mind and body still need to be widely investigated.
